VP22-mediated and light-activated delivery of an anti-c-raf1 antisense oligonucleotide improves its activity after intratumoral injection in nude mice

By Zavaglia D.   Normand N.   Brewis N.   O'Hare P.   Favrot M.-C.   Coll J.-l.  

Molecular Therapy, Vol. 8, Iss. 5, 2003-11 ,pp. : 840-845

Elsevier

Access to resources Recommend Favorite

VP22 flips the switch on cell death

By Weitzman M.D.  

Molecular Therapy, Vol. 7, Iss. 2, 2003-02 ,pp. : 146-147

Elsevier

Access to resources Recommend Favorite

Intercellular Trafficking of Adenovirus-Delivered HSV VP22 from the Retinal Pigment Epithelium to the Photoreceptors—Implications for Gene Therapy

By Cashman S.M.   Sadowski S.L.   Morris D.J.   Frederick J.   Kumar-Singh R.  

Molecular Therapy, Vol. 6, Iss. 6, 2002-12 ,pp. : 813-823

Academic Press

Access to resources Recommend Favorite

Consideration and Checkboxes: Incorporating Ethics and Science into the 3Rs

By Landi Margaret S   Shriver Adam J   Mueller Anne  

Journal of the American Association for Laboratory Animal Science, Vol. 54, Iss. 2, 2015-03 ,pp. : 224-230

American Association for Laboratory Animal Science

Access to resources Recommend Favorite

Toward Intracellular Targeted Delivery of Cancer Therapeutics: Progress and Clinical Outlook for Brain Tumor Therapy

By Pandya Hetal   Debinski Waldemar  

BioDrugs, Vol. 26, Iss. 4, 2012-08 ,pp. : 235-244

Adis International

Access to resources Recommend Favorite